γ-catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth

Oncogene

Volumn 21, Issue 49, 2002, Pages 7497-7506

  Winn, Robert A ^a,b   Bremnes, Roy M ^b   Bemis, Lynne ^b   Franklin, Wilbur A ^b   Miller, York E ^a,b   Cool, Carlyne ^b   Heasley, Lynn E ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Cell transformation; Lung cancer; NSCLC; Tumor suppressor; catenin

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA CATENIN; HISTONE DEACETYLASE; PLAKOGLOBIN; TRICHOSTATIN A;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL TRANSFORMATION; COLON CARCINOMA; CONTROLLED STUDY; DNA METHYLATION; GENE ACTIVATION; GENE ACTIVITY; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN CONTENT; REPORTER GENE; SIGNAL TRANSDUCTION; STAINING; TUMOR SUPPRESSOR GENE;

BETA CATENIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; DESMOPLAKINS; GAMMA CATENIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 85047696569     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205963     Document Type: Article

References (41)

1. Adjei A. (2001). J. Natl. Cancer Inst., 93, 1062-1074.
2. Bates RC, Buret A, van Helden DF, Horton MA and Burns GF. (1994). J. Cell Biol., 125, 403-415.
3. Beekman A, Helfrich B, Bunn Jr PA and Heasley LE. (1998). Cancer Res., 58, 910-913.
4. Brabletz T, Jung A, Dag S, Hlubek F and Kirchner T. (1999). Am. J. Pathol., 155, 1033-1038.
5. Calvo R, West J, Franklin W, Erickson P, Bemis L, Li E, Helfrich B, Bunn P, Roche J, Brambilla E, Rosell R, Gemmill RM and Drabkin HA. (2000). Proc. Natl. Acad. Sci. USA. 97, 12776-12781.
6. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P and Matrisian LM. (1999). Oncogene, 18, 2883-2891.
7. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A and Perret C. (1998). Proc. Natl. Acad. Sci. USA, 95, 8847-8851.
8. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S and Hirohashi S. (1998). Cancer Res., 58, 3526-3528.
9. Graziano SL, Gamble GP, Newman NB, Abbott LZ, Rooney M, Mookherjee S, Lamb ML, Kohman LJ and Poiesz BJ. (1999). J. Clin. Oncol., 17, 668-675.
10. Greenlee R, Hill-Harmon MB, Murray T and Thun M. (2001). CA Cancer J. Clin. Oncol., 51, 15-36.
11. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW. (1998). Science, 281, 1509-1518.
12. Howe LR, Subbaramaiah K, Brown AM and Dannenberg AJ. (2001). Endocr. Relat. Cancer, 8, 97-114.
13. Hsieh ET, Shepherd FA and Tsao MS. (2000). Lung Cancer, 29, 151-157.
14. Huber OKR, McLaughlin J, Ohsugi M, Herrmann BG and Kemler R. (1996). Mech. Dev., 59, 3-10.
15. Karnovsky A and Klymkowsky MW. (1995). PNAS, 92, 4522-4526.
16. Kinzler KW and Vogelstein B. (1996). Cell, 87, 159-170.
17. Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR and Fearon ER. (2000). Genes Dev., 14, 1319-1331.
18. Landau NR and Littman DR. (1992). J. Virol., 66, 5110-5113.
19. Miravet S, Piedra J, Miro F, Itarte E, Garcia de Herreros A and Dunach M. (2002). J. Biol. Chem., 277, 1884-1891.
20. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW. (1997). Science, 275, 1787-1790.
21. Nicholson RI, Gee JM and Harper ME. (2001). Eur. J. Cancer, 37 (Suppl 4): 9-15.
22. Ohsaki Y, Tanno S, Fujita Y, Toyoshima E, Fujiuchi S, Nichigaki Y, Ishida S, Nagase A, Miyokawa N, Hirata S and Kikuchi K. (2000). Oncol. Rep., 7, 603-607.
23. Ozawa M, Baribault H and Kemler R. (1989). EMBO J., 8, 1711-1717.
24. Pantel K, Passlick B, Vogt J, Stosiek P, Angstwurm M, Seen-Hibler R, Hassinger K, Thetter O, Izbicki JR and Riethmuller G. (1998). J. Clin. Oncol., 16, 1407-1413.
25. Parker H, Li Z, Sheinin H, Lauzon G and Pasdar M. (1998). Cell Motility Cytoskel., 40, 87-100.
26. Pear WS, Nolan GP, Scott ML and Baltimore D. (1993). Proc. Natl. Acad. Sci. USA, 90, 8392-8396.
27. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D and Levine AJ. (1998). Proc. Natl. Acad. Sci. USA, 95, 14717-14722.
28. Pirinen RT, Hirvikoski P, Johansson RT, Hollmen S and Kosma VM. (2001). J. Clin. Pathol., 54, 391-395.
29. Polakis P. (2000). Genes Dev., 14, 1837-1851.
30. Potter E, Braun S, Lehmann U and Brabant G. (2001). Eur. J. Endocrinol., 145, 625-633.
31. Rimm DL, Caca K, Hu G, Harrison FB and Fearon ER. (1999). Am. J. Pathol., 154, 325-329.
32. Sadot E, Simcha I, Shtutman M, Ben-Ze'ev A and Geiger B. (1998). Proc. Natl. Acad. Sci. USA, 95, 15339-15344.
33. Sekido Y, Fong KM and Minna JD. (1998). Biochim. Biophys. Acta, 1378, F21-F59.
34. Shtutman M, Zhurinsky J, Simcha I, Albanese C, d'Amico M, Pestell R and Ben-Ze'ev A. (1999). Proc. Natl. Acad. Sci. USA, 96, 5522-5527.
35. Simcha I, Geiger B, Yehuda-Levenberg S, Salomon D and Ben-Ze'ev A. (1996). J. Cell Biol., 133, 199-209.
36. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW. (2001). Nature, 409, 207-211.
37. Tetsu O and McCormick F. (1999). Nature, 398, 422-426.
38. Toyoyama H, Nuruki K, Ogawa H, Yanagi M, Matsumoto H, Nishijima H, Shimotakahara T, Aikou T and Ozawa M. (1999). Oncol. Rep., 6, 81-85.
39. Ueda M, Gemmill RM, West J, Winn R, Sugita M, Tanaka N, Ueki M and Drabkin HA. (2001). Br. J. Cancer, 85, 64-68.
40. Westra WH, Baas IO, Hruban RH, Askin FB, Wilson K, Offerhaus GJ and Slebos RJ. (1996). Cancer Res., 56, 2224-2228.
41. Zhurinsky J, Shtutman M and Ben-Ze'ev A. (2000). Mol. Cell. Biol., 20, 4238-4252.